To study the immediate effect of exposure to TNFi antibodies, sPD-L1 was measured in serum samples of RA patients (Figure 3C) before and 24 h after their first infusion of 200 mg of infliximab. This evidence concerns the gene SPDL1 and rheumatoid arthritis.